Back
Product details:
CAS
154229-19-3
Purity
95%
Abiraterone is an orally active inhibitor of the steroidal enzyme CYP17A1. Abiraterone is a derivative of steroidal progesterone and is an innovative drug that offers clinical benefit to patients with hormone refractory prostate cancer. It is used in combination with prednisone for the treatment of metastatic, castration-resistant prostate cancer.
Properties
Name
Abiraterone
Smiles
C[C@@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]2CC=C1C=5C=CC=NC5
Targets
Please log in to see this information
(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol | 17-(3-pyridinyl)androsta-5,16-diene-3β-ol | 17-(3-pyridyl)androsta-5,16-dien-3β-ol | 3'-(3β-hydroxyandrosta-5,16-dien-17-yl)pyridine | ABT | Abi | CB-7598 | abiraterone | abiraterone acetate
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
Get a quoteQuantity
1
Total amount
$ 19
This compound is considered a Dangerous good for shipping. Our team will contact you with details on lead time and costs
(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol | 17-(3-pyridinyl)androsta-5,16-diene-3β-ol | 17-(3-pyridyl)androsta-5,16-dien-3β-ol | 3'-(3β-hydroxyandrosta-5,16-dien-17-yl)pyridine | ABT | Abi | CB-7598 | abiraterone | abiraterone acetate
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.